Showing results (211-220 of 225) with videos related to
Sort By:
Pageof 23
Circulation. Cardiovascular Quality and Outcomes|August 25, 2011
Use of hundreds of electrocardiographic biomarkers for prediction of mortality in postmenopausal women: the Women's Health InitiativeEiran Z Gorodeski, Hemant Ishwaran, Udaya B Kogalur, et al.The American Journal of Cardiology|October 23, 2008
Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarctionHerbert D Aronow, A Michael Lincoff, Martin J Quinn, et al.The American Journal of Cardiology|June 27, 2000
Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study GroupL J Shaw, R Hachamovitch, G V Heller, et al.The New England Journal of Medicine|June 28, 2002
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunctionRonnier J Aviles, Arman T Askari, Bertil Lindahl, et al.Transfusion|April 11, 2012
The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshopMorris A Blajchman, Jeffrey L Carson, John W Eikelboom, et al.The American Journal of Cardiology|July 16, 2005
Usefulness of tissue doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study)Richard W Troughton, David L Prior, Christopher M Frampton, et al.Journal of the American College of Cardiology|March 18, 1999
The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study GroupL J Shaw, R Hachamovitch, D S Berman, et al.American Heart Journal|December 18, 2002
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B)Debabrata Mukherjee, Kenneth W Mahaffey, David J Moliterno, et al.Journal of the American College of Cardiology|July 17, 2012
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood InstituteMark A Hlatky, Pamela S Douglas, Nakela L Cook, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2004
Impact of donor spontaneous intracranial hemorrhage on outcome after heart transplantationMohamad H Yamani, Michael S Lauer, Randall C Starling, et al.Pageof 23